Stock Analysis on Net
Stock Analysis on Net

Abiomed Inc. (NASDAQ:ABMD)

$22.49

This company has been moved to the archive! The financial data has not been updated since November 3, 2022.

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity

Paying user area

Try for free

Abiomed Inc. pages available for free this week:

The data is hidden behind: . Unhide it.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Abiomed Inc., common-size consolidated balance sheet: liabilities and stockholders’ equity

Microsoft Excel
Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019 Mar 31, 2018 Mar 31, 2017
Accounts payable
Employee compensation
Research and development
Marketing
Warranty
Sales and income taxes
Professional, legal and accounting fees
Other
Accrued expenses
Deferred revenue
Other current liabilities
Current portion of capital lease obligation
Current liabilities
Other long-term liabilities
Contingent consideration
Deferred tax liabilities
Capital lease obligation, net of current portion
Long-term liabilities
Total liabilities
Class B Preferred Stock, $.01 par value; none issued and outstanding
Common stock, $.01 par value
Additional paid in capital
Retained earnings (accumulated deficit)
Treasury stock at cost
Accumulated other comprehensive loss
Stockholders’ equity
Total liabilities and stockholders’ equity

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).

Accounts payable
Accounts payable as a percentage of total liabilities and stockholders' equity exhibited a consistent downward trend from 3.75% in 2017 to 2.11% in 2022, indicating a relative reduction in short-term payables over time.
Employee compensation
This metric decreased from 4.23% in 2017 to 2.65% in 2020, followed by a gradual increase reaching 3.03% in 2022, suggesting fluctuations in compensation costs relative to total liabilities and equity.
Research and development
R&D expenses remained relatively stable, fluctuating slightly around an average near 0.43%, with minor increases in 2020 and 2021 and a slight decrease to 0.44% in 2022.
Marketing
Marketing expenses showed a decline from 0.33% in 2017 to a low of 0.14% in 2019, with some fluctuation thereafter, including a modest peak of 0.25% in 2021 before returning to 0.14% in 2022, indicating generally low and variable marketing spend relative to total liabilities and equity.
Warranty
Warranty liabilities remained stable around the 0.12%-0.15% range, showing minimal variation over the period.
Sales and income taxes
These taxes demonstrated notable volatility, increasing from 0.58% in 2017 to a peak of 1.78% in 2020, before sharply declining to 0.12% by 2022, indicating fluctuating tax burdens.
Professional, legal and accounting fees
These fees remained low and mostly stable, with minor variations, peaking at 0.57% in 2020 before declining to 0.09% by 2022.
Other expenses
Other expenses declined significantly from 0.79% in 2017 to about 0.30-0.42% range in subsequent years, reflecting a reduction and stabilization in miscellaneous costs.
Accrued expenses
Accrued expenses decreased from 6.85% in 2017 to 4.34% in 2022, with minor fluctuations, indicating improved management or reduced accruals relative to total liabilities and equity.
Deferred revenue
This liability was relatively stable, holding close to 1.5%-1.9% range throughout the period.
Other current liabilities
Other current liabilities appeared from 2020 at 0.40%, decreasing slightly to 0.25% by 2022, reflecting emerging but controlled current liabilities not elsewhere classified.
Current portion of capital lease obligation
This obligation was present in 2017 at 0.15% but was not reported in subsequent years, suggesting elimination or reclassification.
Current liabilities
Current liabilities declined steadily from 12.65% in 2017 to 8.27% in 2022, indicating a reduction in short-term obligations relative to the company's capital structure.
Other long-term liabilities
These liabilities fluctuated, initially low at 0.59% in 2017, dropping to 0.10% in 2018 and 2019, then increasing to 0.76% in 2020 before declining again to 0.56% in 2022, showing some variability but remaining modest overall.
Contingent consideration
This liability decreased from 1.66% in 2017 to 0.74% in 2020, followed by a rise to 1.65% in 2021 and dropping again to 1.29% in 2022, indicating fluctuations possibly related to deal-related obligations or uncertain future payments.
Deferred tax liabilities
Deferred tax liabilities consistently declined from 0.14% in 2017 to 0.05% in 2022, signaling a diminishing deferred tax burden.
Capital lease obligation, net of current portion
This obligation was identified only in 2017 at 2.82% and was absent in later years, suggesting extinguishment or reclassification.
Long-term liabilities
Long-term liabilities sharply decreased from 5.22% in 2017 to 1.09% in 2019, then increased to 2.39% in 2021 before falling back to 1.89% in 2022, showing varying levels of long-term debt or obligations.
Total liabilities
Total liabilities dropped substantially from 17.87% in 2017 to 10.16% in 2022, marking a significant reduction in the company’s overall liabilities as a proportion of total capital.
Common stock
Common stock remained minimal and stable, declining slightly from 0.08% to 0.03% over six years, indicating negligible changes in par value stock composition.
Additional paid in capital
Additional paid-in capital decreased consistently from 102.82% in 2017 to 51.99% in 2022, showing a significant reduction in capital contributions or premium relative to total capital, possibly due to share repurchases or other capital management activities.
Retained earnings (accumulated deficit)
Retained earnings improved dramatically from a negative 8.53% in 2017 to a positive 57.64% in 2022, reflecting strong accumulated profitability or earnings retention over the period.
Treasury stock at cost
Treasury stock increased its negative impact from -8.5% in 2017 to a low of -21.82% in 2020 before reducing to -18.2% in 2022. This indicates active share repurchase programs, reducing stockholders’ equity temporarily.
Accumulated other comprehensive loss
This loss fluctuated, initially very negative at -3.74% in 2017, improving to near -0.53% in 2018, then varying around -1.3% to -1.6%, indicating persistent but small unrealized losses or adjustments in equity.
Stockholders’ equity
Stockholders’ equity as a percentage of total capital increased overall from 82.13% in 2017 to 89.84% in 2022, reflecting strengthening equity relative to liabilities and an improved capital structure.
Total liabilities and stockholders’ equity
Remained constant at 100%, confirming the proportional relationship among components without data inconsistencies.